Literature DB >> 14609788

Retinal vascular changes and 20-year incidence of lower extremity amputations in a cohort with diabetes.

Scot E Moss1, Ronald Klein, Barbara E K Klein, Tien Y Wong.   

Abstract

OBJECTIVE: To examine the association of retinal vascular changes with the incidence of lower extremity amputations (LEAs) in a cohort with diabetes mellitus.
METHODS: Baseline examinations were performed in a cohort of 996 persons with diabetes diagnosed before the age of 30 years and using insulin. History of LEA was obtained at baseline and at 4, 10, 14, and 20 years. The cumulative 20-year incidence of first LEA was calculated by the product-limit method in 906 persons with follow-up information. Retinal arterioles and venules were measured on digitized fundus photographs obtained at baseline by a standard protocol. Generalized arteriolar narrowing was defined as the lowest 25% of the arteriole-venule ratio. Measurements were obtained in at least one eye for 820 persons. Focal arteriolar narrowing and arteriovenous nicking were also determined from fundus photographs by a standard protocol.
RESULTS: The 20-year cumulative incidence of LEAs was 9.9%. The unadjusted risk of undergoing a LEA was higher in persons with generalized arteriolar narrowing than in those without it (15.7% vs 5.7%; odds ratio [OR], 3.08; 95% confidence interval [CI], 1.60-4.68), and in persons with focal narrowing (33.1% vs 6.8%; OR, 5.59; 95% CI, 3.27-9.54). The results for arteriovenous nicking were not significant. With control for age, sex, levels of glycosylated hemoglobin, diastolic blood pressure, and history of ulcers of the feet, the relationships were attenuated but still statistically significant for both generalized narrowing (OR, 1.89; 95% CI, 1.06-3.35) and focal narrowing (OR, 3.56; 95% CI, 1.87-6.78).
CONCLUSION: In persons with diabetes, generalized as well as focal retinal arteriolar narrowing may reflect damage to the microvasculature, which manifests itself elsewhere in the body as a need for LEAs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609788     DOI: 10.1001/archinte.163.20.2505

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

1.  Current and future management of diabetic retinopathy: a personalized evidence-based approach.

Authors:  Ryan J Fante; Thomas W Gardner; Jeffrey M Sundstrom
Journal:  Diabetes Manag (Lond)       Date:  2013-11-01

2.  Energy expenditure and activity of transfemoral amputees using mechanical and microprocessor-controlled prosthetic knees.

Authors:  Kenton R Kaufman; James A Levine; Robert H Brey; Shelly K McCrady; Denny J Padgett; Michael J Joyner
Journal:  Arch Phys Med Rehabil       Date:  2008-07       Impact factor: 3.966

3.  Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes.

Authors:  J Grauslund; L Hodgson; R Kawasaki; A Green; A K Sjølie; T Y Wong
Journal:  Diabetologia       Date:  2009-07-18       Impact factor: 10.122

4.  Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice.

Authors:  Seungjun Lee; Norman R Harris
Journal:  Microcirculation       Date:  2008-07       Impact factor: 2.628

5.  The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.

Authors:  Drazenka Pongrac Barlovic; Valma Harjutsalo; Daniel Gordin; Milla Kallio; Carol Forsblom; George King; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2018-09-26       Impact factor: 19.112

6.  Ozagrel reverses streptozotocin-induced constriction of arterioles in rat retina.

Authors:  Seungjun Lee; Georgia A Morgan; Norman R Harris
Journal:  Microvasc Res       Date:  2008-07-31       Impact factor: 3.514

7.  Retinal vessel diameter and the incidence of coronary artery disease in type 1 diabetes.

Authors:  Rachel G Miller; Catherine T Prince; Ronald Klein; Trevor J Orchard
Journal:  Am J Ophthalmol       Date:  2009-01-18       Impact factor: 5.258

8.  Predicting development of proliferative diabetic retinopathy.

Authors:  Kristen Harris Nwanyanwu; Nidhi Talwar; Thomas W Gardner; James S Wrobel; William H Herman; Joshua D Stein
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

9.  Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients.

Authors:  Anders Boeck Jensen; Pope L Moseley; Tudor I Oprea; Sabrina Gade Ellesøe; Robert Eriksson; Henriette Schmock; Peter Bjødstrup Jensen; Lars Juhl Jensen; Søren Brunak
Journal:  Nat Commun       Date:  2014-06-24       Impact factor: 14.919

10.  MorbiNet: multimorbidity networks in adult general population. Analysis of type 2 diabetes mellitus comorbidity.

Authors:  Alba Aguado; Ferran Moratalla-Navarro; Flora López-Simarro; Victor Moreno
Journal:  Sci Rep       Date:  2020-02-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.